\-\ Texto\\:\\ \ \(0\)\
\-\ none\\ provided\ \(5\)\
\-\ annual\\ screening\\ by\\ multidisciplinary\\ team\\ to\\ include\\ physical\\ exam\\,\\ ophthalmology\\ exam\\,\\ growth\\ measurements\\,\\ developmental\\ assessment\\ and\\ review\\ of\\ school\\ progress\\.\ \(0\)\
\-\ \\â\\€\\¢\\ nf\\ spots\\ in\\ r\\ posterior\\ internal\\ capsule\\.\\ \\ \ \(0\)\
\-\ \\â\\€\\¢\\ l\\ optic\\ glioma\\.\\ \\ \ \(0\)\
\-\ \\â\\€\\¢\\ scoliosis\\ with\\ severe\\ kyphosis\\ of\\ cervical\\ spine\\.\ \(0\)\
\-\ \\â\\€\\¢\\ posterior\\ cervical\\ fusion\\ mass\\.\ \(0\)\
\-\ \\â\\€\\¢\\ dural\\ ectasia\\.\\ \\ widened\\ spinal\\ canal\\.\\ \\ posterior\\ vertebral\\ body\\ scalloping\\.\\ \\ \\ \ \(0\)\
\-\ \\â\\€\\¢\\ syrinx\\.\\ \\ \ \(0\)\
\-\ \\â\\€\\¢\\ plexiform\\ neurofibroma\\ of\\ l\\ apex\\.\ \(0\)\
\-\ neurofibromatosis\\ type\\ 1\\ \\(nf1\\)\\ with\\ optic\\ glioma\\,\\ dural\\ ectasia\\,\\ thoracic\\ syrinx\\.\ \(0\)\
\-\ \\â\\€\\¢\\ neurofibromatosis\\ 1\ \(0\)\
\-\ 10\\ yo\\ girl\\ with\\ known\\ disease\\ for\\ routine\\ followup\ \(1\)\
\-\ nf1\\ or\\ von\\ recklinghausen\\ disease\\ is\\ an\\ autosomal\\ dominant\\ disorder\\,\\ from\\ a\\ mutation\\ on\\ chromosome\\ 17\\.\\ \\ it\\ is\\ found\\ in\\ approximately\\ 1\\ in\\ 3000\\ individuals\\.\\ \\ common\\ findings\\ include\\ caf\\?\\-au\\-lait\\ spots\\,\\ axillary\\ or\\ inguinal\\ freckling\\,\\ neurofibromas\\,\\ optic\\ gliomas\\,\\ lisch\\ nodules\\,\\ a\\ variety\\ of\\ bony\\ lesions\\,\\ including\\ dural\\ ectasia\\ with\\ associated\\ scalloping\\ of\\ the\\ posterior\\ vertebral\\ bodies\\,\\ pseudoarthrosis\\,\\ cns\\ and\\ soft\\ tissue\\ tumors\\,\\ cognitive\\ deficits\\,\\ learning\\ disabilities\\,\\ seizures\\ and\\ macrocephaly\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ectasia\\:\\ 0\\.08715286670466584\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.06597955164614265\ \(0\)\
\-\ dural\\:\\ 0\\.06541088825533566\ \(0\)\
\-\ spots\\:\\ 0\\.06297163242010823\ \(0\)\
\-\ nf1\\:\\ 0\\.06297163242010823\ \(0\)\
\-\ optic\\:\\ 0\\.06245851609902357\ \(0\)\
\-\ syrinx\\:\\ 0\\.0602576417958756\ \(0\)\
\-\ scalloping\\:\\ 0\\.055370214341864045\ \(0\)\
\-\ neurofibromatosis\\:\\ 0\\.0496965669657305\ \(0\)\
\-\ \\-au\\-lait\\:\\ 0\\.0427493223337187\ \(0\)\
\-\ posterior\\:\\ 0\\.041466074709525236\ \(0\)\
\-\ l\\:\\ 0\\.04100565787514077\ \(0\)\
\-\ 3000\\:\\ 0\\.04061529544893888\ \(0\)\
\-\ freckling\\:\\ 0\\.04061529544893888\ \(0\)\
\-\ glioma\\:\\ 0\\.04055446098638517\ \(0\)\
\-\ caf\\:\\ 0\\.03910117927814004\ \(0\)\
\-\ lisch\\:\\ 0\\.03910117927814004\ \(0\)\
\-\ disabilities\\:\\ 0\\.03910117927814004\ \(0\)\
\-\ multidisciplinary\\:\\ 0\\.03696715239336022\ \(0\)\
\-\ recklinghausen\\:\\ 0\\.03696715239336022\ \(0\)\
\-\ nf\\:\\ 0\\.03615583302584834\ \(0\)\
\-\ learning\\:\\ 0\\.03615583302584834\ \(0\)\
\-\ vertebral\\:\\ 0\\.03559785705697114\ \(0\)\
\-\ plexiform\\:\\ 0\\.03483312550858041\ \(0\)\
\-\ pseudoarthrosis\\:\\ 0\\.03483312550858041\ \(0\)\
\-\ kyphosis\\:\\ 0\\.03427859647880238\ \(0\)\
\-\ chromosome\\:\\ 0\\.03331900933778156\ \(0\)\
\-\ neurofibromas\\:\\ 0\\.03331900933778156\ \(0\)\
\-\ macrocephaly\\:\\ 0\\.03289773192897348\ \(0\)\
\-\ cervical\\:\\ 0\\.032685172700964514\ \(0\)\
\-\ 17\\.\\:\\ 0\\.032144569594022565\ \(0\)\
\-\ 1\\:\\ 0\\.03210515317831116\ \(0\)\
\-\ ophthalmology\\:\\ 0\\.030373663085489867\ \(0\)\
\-\ measurements\\:\\ 0\\.02989486425282815\ \(0\)\
\-\ cognitive\\:\\ 0\\.02989486425282815\ \(0\)\
\-\ gliomas\\:\\ 0\\.029670866282202904\ \(0\)\
\-\ school\\:\\ 0\\.02885954691469102\ \(0\)\
\-\ mutation\\:\\ 0\\.028674855757789598\ \(0\)\
\-\ von\\:\\ 0\\.028323848523586062\ \(0\)\
\-\ scoliosis\\:\\ 0\\.028156750111404057\ \(0\)\
\-\ team\\:\\ 0\\.02698231036764506\ \(0\)\
\-\ widened\\:\\ 0\\.026725520029911208\ \(0\)\
\-\ variety\\:\\ 0\\.02660167530669966\ \(0\)\
\-\ individuals\\:\\ 0\\.02624672119724949\ \(0\)\
\-\ autosomal\\:\\ 0\\.02602272322662425\ \(0\)\
\-\ progress\\:\\ 0\\.025402812512643282\ \(0\)\
\-\ inguinal\\:\\ 0\\.025306238098600144\ \(0\)\
\-\ include\\:\\ 0\\.02523319461084512\ \(0\)\
\-\ neurofibroma\\:\\ 0\\.024936742000319888\ \(0\)\
\-\ axillary\\:\\ 0\\.02442700607405716\ \(0\)\
\-\ capsule\\:\\ 0\\.024346650957579326\ \(0\)\
\-\ \\,\\:\\ 0\\.02422142691470466\ \(0\)\
\-\ assessment\\:\\ 0\\.024189530098896798\ \(0\)\
\-\ apex\\:\\ 0\\.023140409558788946\ \(0\)\
\-\ cns\\:\\ 0\\.023015090355137796\ \(0\)\
\-\ dominant\\:\\ 0\\.022953532251121\ \(0\)\
\-\ annual\\:\\ 0\\.02254167858322759\ \(0\)\
\-\ followup\\:\\ 0\\.02147010513458949\ \(0\)\
\-\ bodies\\:\\ 0\\.021070179308389895\ \(0\)\
\-\ developmental\\:\\ 0\\.02090174388162056\ \(0\)\
\-\ deficits\\:\\ 0\\.020580229713305625\ \(0\)\
\-\ r\\:\\ 0\\.020426549951767403\ \(0\)\
\-\ disorder\\:\\ 0\\.02020412990287328\ \(0\)\
\-\ fusion\\:\\ 0\\.02006090588432126\ \(0\)\
\-\ exam\\:\\ 0\\.019760357262626718\ \(0\)\
\-\ growth\\:\\ 0\\.01955606313759105\ \(0\)\
\-\ review\\:\\ 0\\.01949226650321029\ \(0\)\
\-\ provided\\:\\ 0\\.019397998468649605\ \(0\)\
\-\ seizures\\:\\ 0\\.019336078249809673\ \(0\)\
\-\ screening\\:\\ 0\\.019184391731201823\ \(0\)\
\-\ nodules\\:\\ 0\\.018644836133698692\ \(0\)\
\-\ routine\\:\\ 0\\.01803392996921051\ \(0\)\
\-\ bony\\:\\ 0\\.01798608274973024\ \(0\)\
\-\ canal\\:\\ 0\\.017868333814180064\ \(0\)\
\-\ \\?\\:\\ 0\\.017551997371707928\ \(0\)\
\-\ thoracic\\:\\ 0\\.017337144768969748\ \(0\)\
\-\ tumors\\:\\ 0\\.01689324398773948\ \(0\)\
\-\ including\\:\\ 0\\.016239045478910124\ \(0\)\
\-\ spinal\\:\\ 0\\.016104085317787294\ \(0\)\
\-\ girl\\:\\ 0\\.015812512794683146\ \(0\)\
\-\ type\\:\\ 0\\.015161180149194264\ \(0\)\
\-\ 10\\:\\ 0\\.015161180149194264\ \(0\)\
\-\ internal\\:\\ 0\\.01507829405988827\ \(0\)\
\-\ spine\\:\\ 0\\.014811071294764989\ \(0\)\
\-\ disease\\:\\ 0\\.014702500433849517\ \(0\)\
\-\ body\\:\\ 0\\.014606651119416234\ \(0\)\
\-\ known\\:\\ 0\\.014231847812967472\ \(0\)\
\-\ found\\:\\ 0\\.01417381902343217\ \(0\)\
\-\ approximately\\:\\ 0\\.013914830666082015\ \(0\)\
\-\ severe\\:\\ 0\\.013838472631926339\ \(0\)\
\-\ yo\\:\\ 0\\.013533429070014535\ \(0\)\
\-\ lesions\\:\\ 0\\.012039792138652356\ \(0\)\
\-\ common\\:\\ 0\\.011769827431349458\ \(0\)\
\-\ none\\:\\ 0\\.01115641845741056\ \(0\)\
\-\ physical\\:\\ 0\\.011034238260953885\ \(0\)\
\-\ soft\\:\\ 0\\.010952246126281841\ \(0\)\
\-\ tissue\\:\\ 0\\.010660111518171545\ \(0\)\
\-\ associated\\:\\ 0\\.0106129608521458\ \(0\)\
\-\ or\\:\\ 0\\.010542344725933763\ \(0\)\
\-\ it\\:\\ 0\\.010109728339647456\ \(0\)\
\-\ findings\\:\\ 0\\.009572825977841893\ \(0\)\
\-\ by\\:\\ 0\\.007488794227604604\ \(0\)\
\-\ from\\:\\ 0\\.006665451121864275\ \(0\)\
\-\ in\\:\\ 0\\.006653640475898762\ \(0\)\
\-\ mass\\:\\ 0\\.006255057931302971\ \(0\)\
\-\ an\\:\\ 0\\.006219288759393315\ \(0\)\
\-\ is\\:\\ 0\\.0059188502987865856\ \(0\)\
\-\ a\\:\\ 0\\.004174734755985276\ \(0\)\
\-\ for\\:\\ 0\\.003837411308645869\ \(0\)\
\-\ on\\:\\ 0\\.0038099526966601477\ \(0\)\
\-\ \\(\\:\\ 0\\.0038019038223361078\ \(0\)\
\-\ \\)\\:\\ 0\\.0037554615374384478\ \(0\)\
\-\ of\\:\\ 0\\.003065889494683906\ \(0\)\
\-\ and\\:\\ 0\\.0028422474589297653\ \(0\)\
\-\ with\\:\\ 0\\.0024632458124187314\ \(0\)\
\-\ \\.\\:\\ 0\\.0024289156277131664\ \(0\)\
\-\ to\\:\\ 0\\.0022477268865420327\ \(0\)\
\-\ the\\:\\ 0\\.0007276278142296094\ \(0\)\
